NCT06518746Recruiting
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
Source: ClinicalTrials.gov · Last updated 18 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The "Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation" study is open to a subset of patients with disorders of sex development (DSD) which is associated with the risk of malignancy and a high risk of infertility or sterility. For these patients, experimental gonadal tissue cryopreservation is the only fertility preservation option available. The overall objective of this study is to determine the safety and efficacy of gonadal tissue cryopreservation as a method of preserving fertility and/or restoring hormonal function in patients with gonadal dysgenesis who are at risk of decreased fertility potential or malignancy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 3 Jul 2024
- Start date
- 16 Aug 2021
- Primary completion date
- 30 Dec 2030
- Lead sponsor
- University of Colorado, Denver
- Diseases
- Ovarian cancer, Childhood cancers
- NCT number
- NCT06518746
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 16 Aug 2021 to the primary completion date, 30 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients 18 and older unable to provide consent (i.e. significant psychiatric problems/cognitive delay)
Age
- Patients 7-17 years of age unable to provide assent (i.e. significant psychiatric problems/cognitive delay)
Other
- Pregnancy
- Patients likely to retain inherent fertility and reproductive function
- Patients deemed high risk for perioperative complications
Who the study is looking for
- \< 30 years of age
- Individuals diagnosed with a disorder of sex development who have any risk for malignancy in their gonadal tissue and will have their gonads removed for a clinical indication
- Individuals diagnosed with a disorder of sex development who are at risk of primary ovarian insufficiency (POI) due to an underlying genetic condition
Age in the registry: - to 30 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Colorado Coordinator of this site? Confirm its status | Aurora | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.